Rethinking First-Line Immunosuppression for Idiopathic FSGS

Clin J Am Soc Nephrol. 2016 Mar 7;11(3):372-3. doi: 10.2215/CJN.00780116. Epub 2016 Feb 16.

Authors

Jordana B Cohen¹, Jonathan J Hogan²

Affiliations

¹ Renal, Electrolyte, and Hypertension Division, University of Pennsylvania, Philadelphia, Pennsylvania jco@mail.med.upenn.edu.
² Renal, Electrolyte, and Hypertension Division, University of Pennsylvania, Philadelphia, Pennsylvania.

No abstract available

Keywords: Immune Tolerance; focal segmental glomerulosclerosis; glomerular disease; immunosuppression; treatment.

Publication types

Editorial
Research Support, N.I.H., Extramural
Comment

MeSH terms

Glomerulosclerosis, Focal Segmental*
Humans
Immune Tolerance
Immunosuppression Therapy*
Kidney Glomerulus

Grants and funding